Biography

Rob Aarnoutse, PharmD PhD, is professor, hospital pharmacist and clinical pharmacologist, working at the Department of Pharmacy and with the Radboud Institute for Medical Innovation at Radboud university medical center, Nijmegen, The Netherlands. His research is focused on drug treatment of mycobacterial infections, i.e. tuberculosis (TB) and non-tuberculous mycobacterial (NTM) disease. The central concept in his work is that efficacy and toxicity of drugs are dependent on drug concentrations achieved either systemically or locally. His research portfolio reaches from molecular pharmacological research, to pharmacokinetic studies in small patients groups and in clinical trials, and pharmacological research in clinical practice.

Expertise

TB Diagnostics
Public Health

Key Impacts

Depression and TB: Double trouble?

Impact details available upon request.

Source: Conference 2024
Pharmacokinetics (PK) and pharmacodynamics (PD) of TB drugs in the SURE trial

Impact details available upon request.

Source: Conference 2024